The discussion assignment is a blog.  A blog is a conversational, informal written piece on a topic.  Your topic is assigned below; your topic is an illness and the FDA-approved treatment options to treat the illness.  In your blog, you will create a presentation to share with your peers. Your presentation is a teaching moment in which you will have the opportunity to educate your peers about a specific disorder.   You are to construct a blog post, not to exceed 1,500–2,000 words.  This blog post must be written for a PMHNP provider audience and include all of the required information: 
Post your Blog response by doing the following:
• Identify the substance or addiction with discussion on pertinent diagnostic criteria for the use disorder.
• Identify the street names of the substance for the use disorder.
• Describe how someone can use or abuse the substance (oral, smoke, IV, etc.).
• Describe the symptoms of someone under the influence of this substance.
• Describe the symptoms of someone under the withdrawal of this substance.
After describing the substance, discuss the treatment recommendations by doing the following:
• Identify the first-line treatment options.
• Identify the FDA-approved medications for the substance.
Note: If there are no FDA-approved medications, describe any evidenced-based, clinically acceptable off-label medications to treat the illness.
• Identify the proposed mechanisms of action for the medication to treat the illness.
• Describe the common side effects of the medication.
• Describe how the patient should take the medication.
• Identify any baseline and/or ongoing tests and assessment(s) needed when taking the medication.
• Describe the non-pharmacologic intervention recommendations.
This Assignment requires a minimum of three (3) peer-reviewed, evidence-based scholarly references outside of course Learning Resources.
Note: You will need to include the APA formatting citation of all references used with a Reference list.
 
Below is my assigned topic:
Binge Eating Disorder (BED)
o Lisdexamphetamine